Clinical Cancer Research 2005, 11:7362–7368.PubMedCrossRef 49. Yu JR, Wu YJ, Qin Q, Lu KZ, Yan S, Liu XS, Zheng SS: Expression of cyclooxygenase-2 in gastric cancer and its relation to liver metastasis and long-term prognosis. World J Gastroenterol 2005, 11:4908–4911.PubMed 50. Lim HY, Joo HJ, Choi https://www.selleckchem.com/products/s63845.html JH, Yi JW, Yang MS, Cho DY, Kim HS, Nam DK, Lee KB, Kim HC: Increased expression of
cyclooxygenase-2 protein in human gastric carcinoma. Clin Cancer Res 2000, 6:519–525.PubMed 51. Kyzas PA, Stenfanou D, Agnantis NJ: COX-2 expression correlates with VEGF-C and lymph node metastases in patients with head and neck squamous cell carcinoma. Mod Pathol 2005, 18:153–160.PubMedCrossRef 52. Zhang J, Ji J, Yuan F, Zhu L, Yan C, Yu YY, Liu BY, Zhu ZG, Lin YZ: Cyclooxygenase-2 expression is associated with VEGF-C and lymph node metastases in gastric cancer patients. Biomed Pharmacother 2005,59(Suppl 2):285–288.CrossRef 53. Juuti A, Louhimo J, Nordling S, Ristimäki
A, Haglund C: Cyclooxygenase-2 expression see more correlates with poor prognosis in pancreatic cancer. J Clin Pathol 2006, 59:382–386.PubMedCrossRef 54. Byun JH, Lee MA, Roh SY, Shim BY, Hong SH, Ko YH, Ko SJ, Woo IS, Kang JH, Hong YS, Lee KS, Lee AW, Park GS, Lee KY: Association between Cyclooxygenase-2 and Matrix Metalloproteinase-2 Expression in Non-Small Cell Lung Cancer. Jpn J Clin Oncol 2006, 36:263–268.PubMedCrossRef 55. Jeon YT, Kang S, Kang DH, Yoo KY, Park IA, Bang YJ, Kim JW, Park NH, Kang SB, Lee HP, Song YS: Cancer Epidemiol Biomarkers Prev. 2004, 13:1538–1542.PubMed 56. Van Dyke AL, Cote ML, Prysak GM, Claeys GB, Wenzlaff AS, Murphy VC, Lonardo F, Schwartz AG: COX-2/EGFR expression and survival among women also with adenocarcinoma of the lung. Carcinogenesis 2008, 29:1781–1787.PubMedCrossRef 57. Nakamoto
RH, selleck inhibitor Uetake H, Iida S, Kolev YV, Soumaoro LT, Takagi Y, Yasuno M, Sugihara K: Correlations between cyclooxygenase-2 expression and angiogenic factors in primary tumors and liver metastases in colorectal cancer. Jpn J Clin Oncol 2007, 37:679–685.PubMedCrossRef 58. Paydas S, Ergin M, Seydaoglu G, Erdogan S, Yavuz S: Prognostic [corrected] significance of angiogenic/lymphangiogenic, anti-apoptotic, inflammatory and viral factors in 88 cases with diffuse large B cell lymphoma and review of the literature. Leuk Res 2009, 33:1627–1635.PubMedCrossRef 59. Von Rahden BH, Brücher BL, Langner C, Siewert JR, Stein HJ, Sarbia M: Expression of cyclo-oxygenase 1 and 2, prostaglandin E synthase and transforming growth factor beta1, and their relationship with vascular endothelial growth factors A and C, in primary adenocarcinoma of the small intestine. Br J Surg 2006, 93:1424–1432.PubMedCrossRef Competing interests The authors declare that they have no competing interests.